About Lowell Therapeutics
Lowell Therapeutics is a company based in Lowell (United States) founded in 2018 was acquired by AcelRx in November 2021. Lowell Therapeutics has raised $1 million across 1 funding round from investors including Talphera. Lowell Therapeutics operates in a competitive market with competitors including Sentien Biotechnologies, Accord Innovations, Renapta, Kalera Medical and 3ive Labs, among others.
- Headquarter Lowell, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Lowell Therapeutics
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Lowell Therapeutics
Lowell Therapeutics has successfully raised a total of $1M through 1 strategic funding round. The most recent funding activity was a Seed round of $1 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lowell Therapeutics
Lowell Therapeutics has secured backing from 1 investor. Prominent investors backing the company include Talphera.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Innovative therapies are developed by Talphera for medically supervised settings.
|
Locked | Locked | Locked |
Investor details for Lowell Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lowell Therapeutics
Investment portfolio details for Lowell Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lowell Therapeutics
Detailed financials for Lowell Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lowell Therapeutics Comparisons
Peer comparison for Lowell Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lowell Therapeutics
Lowell Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sentien Biotechnologies, Accord Innovations, Renapta, Kalera Medical and 3ive Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stem cell-based devices for acute organ failure are developed.
|
|
| Locked | Locked | Locked |
Device for early acute kidney injury diagnosis is developed.
|
|
| Locked | Locked | Locked |
Offers a device for supporting end-stage renal impaired patients.
|
|
| Locked | Locked | Locked |
Develops innovative vacuum-assisted devices for kidney stone retrieval.
|
|
| Locked | Locked | Locked |
Develops innovative devices to restore kidney function.
|
Detailed competitors of Lowell Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lowell Therapeutics
Complete news archive for Lowell Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lowell Therapeutics
Lowell Therapeutics was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Lowell Therapeutics is headquartered in Lowell, United States. It is registered at Lowell, Massachusetts, United States.
Lowell Therapeutics is a funded company, having raised a total of $1M across 1 funding round to date.
Lowell Therapeutics was founded in 2018 and is based in Lowell, United States. Focus is placed on the biotechnology sector, where anticoagulants are developed specifically for acute kidney diseases. Operations center on creating targeted therapies, including the lead product Niyad, a small-molecule, short-acting anticoagulant designed for use in continuous renal replacement therapy. Geographic operations remain centered in the United States.
Lowell Therapeutics's top competitors include Sentien Biotechnologies, Accord Innovations and Renapta.
Lowell Therapeutics has 1 investor. Key investors include Talphera.